Cardiac Procedure Performed with Impella 2.5 Heart Pump
November 10, 2010
The Tampa Bay Heart Institute at Northside Hospital Performs Cardiac Procedure Utilizing the Impella 2.5 Heart Pump
November 10, 2010 – St. Petersburg, FL– Northside Hospital recently performed its first cardiac interventional procedure using the Impella 2.5 heart pump developed by Abiomed. Interventional cardiologist, Stephen Minor, M.D.,FACC, performed this minimally invasive, catheter based procedure utilizing revolutionary new technology which provides partial circulatory support via a small pump inserted into the heart without the need for any incisions. This device supplements traditional coronary angioplasty for patients who are considered too high-risk for cardiac bypass surgery given their current health condition.
The FDA approved Impella 2.5 device temporarily unloads the workload on the heart while assisting the heart’s own natural pumping function. This helps to provide adequate blood flow and organ perfusion needed to perform these potentially life-saving cardiac procedures.
As a state-of-the-art cardiac facility, the Tampa Bay Heart Institute at Northside Hospital now offers high-risk surgical patients the opportunity to undergo a less invasive procedure to improve their quality of life, which may not have been otherwise possible. This new technology is now part of the comprehensive cardiovascular and heart recovery program provided to the community by The Tampa Bay Heart Institute at Northside Hospital.
“Patients previously considered high risk for cardiac bypass surgery, now have an alternative revascularization option using the Impella heart assist device,” said Dr. Minor, of the Heart and Vascular Institute of Florida. “We can now perform high-risk interventional cardiac procedures more safely and with quicker recovery times than previously possible. This innovative technology will ultimately translate to saving patient’s lives.”
Northside Hospital & Tampa Bay Heart Institute
Marketing & Public Relations